Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With Psoriasis [Phase 2]

View source ↗

Summary

This update confirms the completion of a Phase 2 trial evaluating VB-201 for psoriasis, including its efficacy and safety assessments.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• VB-201

Snippet

Sponsor: Vascular Biogenics Ltd. operating as VBL Therapeutics | Conditions: Psoriasis | Phase 2 | Status: COMPLETED